Ertaczo is a drug owned by Lacer Pharma Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be May 31, 2014. Details of Ertaczo's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5135943 | 1H-imidazole derivative compounds and pharmaceutical compositions containing the same |
May, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Ertaczo is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Ertaczo's family patents as well as insights into ongoing legal events on those patents.
Ertaczo's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Ertaczo's generic launch date based on the expiry of its last outstanding patent is estimated to be May 31, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Ertaczo Generics:
There are no approved generic versions for Ertaczo as of now.
About Ertaczo
Ertaczo is a drug owned by Lacer Pharma Llc. It is used for treating tinea pedis with a topical treatment. Ertaczo uses Sertaconazole Nitrate as an active ingredient. Ertaczo was launched by Lacer Pharma in 2003.
Approval Date:
Ertaczo was approved by FDA for market use on 10 December, 2003.
Active Ingredient:
Ertaczo uses Sertaconazole Nitrate as the active ingredient. Check out other Drugs and Companies using Sertaconazole Nitrate ingredient
Treatment:
Ertaczo is used for treating tinea pedis with a topical treatment.
Dosage:
Ertaczo is available in cream form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 2% | CREAM | Prescription | TOPICAL |